These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1501220)

  • 21. Enzyme-resistant CCK analogs with high affinities for central receptors.
    Charpentier B; Durieux C; Pelaprat D; Dor A; Reibaud M; Blanchard JC; Roques BP
    Peptides; 1988; 9(4):835-41. PubMed ID: 3226959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological activity of novel, potent and long-acting analogs of AC-CCK-7 with high affinity for peripheral (type A) receptors.
    Danho W; Makofske RC; Swistok J; Michalewsky J; Gabriel T; Marks N; Berg MJ; Baird L; Geiler V; Mackie G
    Pept Res; 1991; 4(2):59-65. PubMed ID: 1815779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
    Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J
    Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic cholecystokinin analogues with high selectivity for central receptors.
    Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
    Weng JH; Blommaert AG; Moizo L; Bado A; Ducos B; Böhme A; Garbay C; Roques BP
    Bioorg Med Chem; 1996 Apr; 4(4):563-73. PubMed ID: 8735845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Models for the A- and B-receptor-bound conformations of CCK-8.
    Nikiforovich GV; Hruby VJ
    Biochem Biophys Res Commun; 1993 Jul; 194(1):9-16. PubMed ID: 8333874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational analysis of CCK-B agonists using 1H-NMR and restrained molecular dynamics: comparison of biologically active Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 and inactive Boc-Trp-(N-Me)Phe-Asp-Phe-NH2.
    Goudreau N; Weng JH; Roques BP
    Biopolymers; 1994 Feb; 34(2):155-69. PubMed ID: 8142585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
    Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP
    J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboxylic acids and tetrazoles as isosteric replacements for sulfate in cholecystokinin analogues.
    Tilley JW; Danho W; Lovey K; Wagner R; Swistok J; Makofske R; Michalewsky J; Triscari J; Nelson D; Weatherford S
    J Med Chem; 1991 Mar; 34(3):1125-36. PubMed ID: 2002454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.
    Dezube M; Sugg EE; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; James MK; Johnson MF; Mosher JT
    J Med Chem; 1995 Aug; 38(17):3384-90. PubMed ID: 7650691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.
    Shiosaki K; Lin CW; Kopecka H; Craig RA; Bianchi BR; Miller TR; Witte DG; Stashko M; Nadzan AM
    J Med Chem; 1992 May; 35(11):2007-14. PubMed ID: 1375964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A71378: a CCK agonist with high potency and selectivity for CCK-A receptors.
    Lin CW; Holladay MW; Witte DG; Miller TR; Wolfram CA; Bianchi BR; Bennett MJ; Nadzan AM
    Am J Physiol; 1990 Apr; 258(4 Pt 1):G648-51. PubMed ID: 2333977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational behavior of cyclic CCK-related peptides determined by 400-MHz 1H-NMR: relationships with affinity and selectivity for brain receptors.
    Roy P; Charpentier B; Durieux C; Dor A; Roques BP
    Biopolymers; 1989 Jan; 28(1):69-79. PubMed ID: 2720122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of analogues of the Des-Phe-NH2 C-terminal hexapeptide of cholecystokinin showing gastrin antagonist activity.
    Laur J; Rodriguez M; Aumelas A; Bali JP; Martinez J
    Int J Pept Protein Res; 1986 Apr; 27(4):386-93. PubMed ID: 3710694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ARL 15849: a selective CCK-A agonist with anorectic activity in the rat and dog.
    Simmons RD; Kaiser FC; Pierson ME; Rosamond JR
    Pharmacol Biochem Behav; 1998 Feb; 59(2):439-44. PubMed ID: 9476993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623).
    Sugg EE; Kimery MJ; Ding JM; Kenakin DC; Miller LJ; Queen KL; Rimele TJ
    J Med Chem; 1995 Jan; 38(1):207-11. PubMed ID: 7837233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
    Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
    J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.